C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Rating of "Hold" from Brokerages

Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC - Get Free Report) have been given a consensus recommendation of "Hold" by the seven brokerages that are covering the firm, MarketBeat reports. Four research analysts have rated the stock with a
Read more...